JP2007508336A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007508336A5 JP2007508336A5 JP2006534638A JP2006534638A JP2007508336A5 JP 2007508336 A5 JP2007508336 A5 JP 2007508336A5 JP 2006534638 A JP2006534638 A JP 2006534638A JP 2006534638 A JP2006534638 A JP 2006534638A JP 2007508336 A5 JP2007508336 A5 JP 2007508336A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- dementia
- acceptable salt
- pharmaceutical composition
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03023635 | 2003-10-16 | ||
| EP04005819 | 2004-03-11 | ||
| PCT/EP2004/011093 WO2005039580A1 (en) | 2003-10-16 | 2004-10-05 | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007508336A JP2007508336A (ja) | 2007-04-05 |
| JP2007508336A5 true JP2007508336A5 (enExample) | 2007-11-29 |
Family
ID=34524707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006534638A Pending JP2007508336A (ja) | 2003-10-16 | 2004-10-05 | モノアミン神経伝達物質再取り込みインヒビター及びアセチルコリンエステラーゼインヒビターを含む医薬組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20050154009A1 (enExample) |
| EP (2) | EP1675591B1 (enExample) |
| JP (1) | JP2007508336A (enExample) |
| AT (1) | ATE519486T1 (enExample) |
| AU (1) | AU2004283425B2 (enExample) |
| CA (1) | CA2542442C (enExample) |
| DK (1) | DK1675591T3 (enExample) |
| MX (1) | MXPA06003762A (enExample) |
| NZ (1) | NZ547152A (enExample) |
| WO (1) | WO2005039580A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070053976A1 (en) * | 2002-05-17 | 2007-03-08 | Eisai R & D Management Co., Ltd. | Novel combination of drugs as antidepressant |
| MXPA06003762A (es) * | 2003-10-16 | 2006-06-14 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un inhibidor de recaptacion de neurotransmisor monoamina y un inhibidor de acetilcolinesterasa. |
| EP1686965A2 (de) * | 2003-11-18 | 2006-08-09 | Boehringer Ingelheim International GmbH | Feste pharmazeutische zubereitungsform |
| AU2005205882A1 (en) * | 2004-01-22 | 2005-08-04 | Neurosearch A/S | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist |
| AU2005205880B2 (en) * | 2004-01-22 | 2010-06-10 | Neurosearch A/S | Compounds for the sustained reduction of body weight |
| WO2005117874A1 (en) * | 2004-06-04 | 2005-12-15 | Neurosearch A/S | MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITOR FOR THE INHIBITION OF BETA-AMYLOID (Aß40 AND Aß42) -GENERATION |
| WO2007028769A1 (en) * | 2005-09-05 | 2007-03-15 | Neurosearch A/S | Monoamine neurotransmitter re-uptake inhibitor for neuroprotection |
| JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体 |
| SI2091948T1 (sl) | 2006-11-30 | 2012-07-31 | Probiodrug Ag | Novi inhibitorji glutaminil ciklaze |
| KR101408454B1 (ko) * | 2006-12-01 | 2014-06-17 | 닛토덴코 가부시키가이샤 | 도네페질 함유 접착 제제의 착색을 억제하는 방법 및 도네페질의 친척 물질의 생성량을 감소시키는 방법 |
| CN101588802A (zh) * | 2006-12-01 | 2009-11-25 | 日东电工株式会社 | 含有稳定化的多奈哌齐的贴剂 |
| ZA200905537B (en) | 2007-03-01 | 2010-10-27 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
| EP2865670B1 (en) | 2007-04-18 | 2017-01-11 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
| JP5421252B2 (ja) * | 2008-05-30 | 2014-02-19 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 経皮吸収製剤 |
| CA2724502A1 (en) * | 2008-05-30 | 2009-12-03 | Nitto Denko Corporation | Adhesive preparation containing donepezil, and package of the same |
| EP2475428B1 (en) | 2009-09-11 | 2015-07-01 | Probiodrug AG | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
| CN109662964A (zh) | 2010-02-09 | 2019-04-23 | 约翰斯.霍普金斯大学 | 用于改善认知功能的方法和组合物 |
| WO2011107530A2 (en) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
| BR112012022478B1 (pt) | 2010-03-10 | 2021-09-21 | Probiodrug Ag | Inibidores heterocíclicos de glutaminil ciclase (qc, ec 2.3.2.5), seu processo de preparação, e composição farmacêutica |
| JP5945532B2 (ja) | 2010-04-21 | 2016-07-05 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
| ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
| JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
| CA2892968A1 (en) * | 2012-11-30 | 2014-06-05 | P2D, Inc. | Substituted benztropine analogs for treatment of dementia |
| WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| CN105142623A (zh) | 2013-03-15 | 2015-12-09 | 艾吉因生物股份有限公司 | 用于改善认知功能的方法和组合物 |
| NZ738682A (en) | 2015-05-22 | 2022-01-28 | Agenebio Inc | Extended release pharmaceutical compositions of levetiracetam |
| EP3461819B1 (en) | 2017-09-29 | 2020-05-27 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
| MX2021004737A (es) * | 2018-10-24 | 2021-06-04 | Saniona As | Composiciones de tropano transdermicas y metodos para usar las mismas. |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US554626A (en) * | 1896-02-11 | murphy | ||
| DK154192D0 (da) * | 1992-12-23 | 1992-12-23 | Neurosearch As | Heterocycliske forbindelser |
| AU671163B2 (en) | 1992-12-23 | 1996-08-15 | Neurosearch A/S | Alkyl substituted heterocyclic compounds |
| US5554626A (en) * | 1992-12-23 | 1996-09-10 | Neurosearch A/S | Substituted heterocyclic compounds as dopamine-reuptake inhibitors |
| AU672644B2 (en) * | 1992-12-23 | 1996-10-10 | Neurosearch A/S | Aryl substituted heterocyclic compounds |
| AU672052B2 (en) | 1992-12-23 | 1996-09-19 | Neurosearch A/S | Antidepressant and antiparkinsonian compounds |
| CZ284379B6 (cs) * | 1994-04-19 | 1998-11-11 | Neurosearch A/S | Tropanové deriváty, způsob jejich přípravy a jejich použití |
| TR199801641T2 (xx) | 1996-02-22 | 1998-11-23 | Neurosearch A/S | Tropan t�revleri bunlar�n haz�rlanmas� ve kullan�m� |
| US6262081B1 (en) * | 1998-07-10 | 2001-07-17 | Dupont Pharmaceuticals Company | Composition for and method of treating neurological disorders |
| AR028782A1 (es) * | 2000-07-05 | 2003-05-21 | Taisho Pharmaceutical Co Ltd | Derivados heterociclicos tetrahidropiridino o piperidino |
| JP2005508872A (ja) * | 2001-05-23 | 2005-04-07 | ニューロサーチ、アクティーゼルスカブ | トロパン誘導体及びこれをモノアミン神経伝達物質再取り込み阻害剤として使用する方法 |
| US20030008791A1 (en) * | 2001-06-06 | 2003-01-09 | Lonza Inc. | Non-alcoholic hand sanitizer |
| DE10148233A1 (de) * | 2001-09-28 | 2003-04-10 | Boehringer Ingelheim Pharma | Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme |
| EP1594874A1 (en) * | 2003-02-12 | 2005-11-16 | Neurosearch A/S | Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| MXPA06003762A (es) * | 2003-10-16 | 2006-06-14 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un inhibidor de recaptacion de neurotransmisor monoamina y un inhibidor de acetilcolinesterasa. |
| AU2005205880B2 (en) * | 2004-01-22 | 2010-06-10 | Neurosearch A/S | Compounds for the sustained reduction of body weight |
| AU2005205882A1 (en) * | 2004-01-22 | 2005-08-04 | Neurosearch A/S | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist |
| WO2005117874A1 (en) * | 2004-06-04 | 2005-12-15 | Neurosearch A/S | MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITOR FOR THE INHIBITION OF BETA-AMYLOID (Aß40 AND Aß42) -GENERATION |
-
2004
- 2004-10-05 MX MXPA06003762A patent/MXPA06003762A/es active IP Right Grant
- 2004-10-05 CA CA2542442A patent/CA2542442C/en not_active Expired - Fee Related
- 2004-10-05 DK DK04790120.2T patent/DK1675591T3/da active
- 2004-10-05 AU AU2004283425A patent/AU2004283425B2/en not_active Ceased
- 2004-10-05 EP EP04790120A patent/EP1675591B1/en not_active Expired - Lifetime
- 2004-10-05 WO PCT/EP2004/011093 patent/WO2005039580A1/en not_active Ceased
- 2004-10-05 NZ NZ547152A patent/NZ547152A/en not_active IP Right Cessation
- 2004-10-05 AT AT04790120T patent/ATE519486T1/de active
- 2004-10-05 JP JP2006534638A patent/JP2007508336A/ja active Pending
- 2004-10-05 EP EP10180538A patent/EP2269608A3/en not_active Withdrawn
- 2004-10-15 US US10/965,994 patent/US20050154009A1/en not_active Abandoned
-
2010
- 2010-04-27 US US12/768,240 patent/US20100210626A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007508336A5 (enExample) | ||
| JP2006506378A5 (enExample) | ||
| AU2004283425B2 (en) | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor | |
| CN110944638A (zh) | 尼拉帕尼组合物 | |
| AU2011365756B2 (en) | Antihypertensive pharmaceutical composition | |
| IL305952A (en) | Melanocortin subtype 2 receptor (MC2R) antagonist for disease treatment | |
| ES2277960T3 (es) | Base libre de la amlodipina. | |
| WO2008005352A3 (en) | Solid dose formulations of a thrombin receptor antagonist | |
| JP2011079854A (ja) | 洞房結節Ｉｆ電流阻害剤およびアンギオテンシン変換酵素阻害剤の新規な組み合わせならびにそれを含む医薬組成物 | |
| RU2611341C2 (ru) | Способ увеличения эффективности терапии аутоиммунных заболеваний, таких как ревматоидный артрит | |
| MXPA01010904A (es) | Utilizacion del saredutant y de sus sales farmaceuticamente aceptables para la preparacion de medicamentos utiles en el tratamiento o la prevencion del conjunto de los trastornos del humor, de los trastornos de adaptacion o de los trastornos mixtos a | |
| US20170326107A1 (en) | 5-HT6 Receptor Antagonists for Use in the Treatment of Alzheimer's Disease with Apathy as Comorbiity | |
| EP2146714B1 (fr) | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson | |
| MY143571A (en) | Eplerenone crystalline form | |
| JP2005515155A5 (enExample) | ||
| JP2000515156A (ja) | 精神病的疾患の治療 | |
| ES2257343T3 (es) | Sal de meglumina de un compuesto de acido quinolincarboxilico especifico activo sobre los receptores de nmda. | |
| JP2002504134A (ja) | 疼痛を治療するためのドラフラジン類似体の使用 | |
| CN101677998B (zh) | 包含西洛他唑的治疗精神分裂症药物 | |
| HU196126B (en) | Process for producing pharmaceutics with analgetic effect | |
| US20220211708A1 (en) | Pharmaceutical combination of pimozide and methotrexate and use thereof | |
| US6962921B2 (en) | Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient | |
| TW201206433A (en) | Association of xanthine oxidase inhibitors and calcium antagonists and use thereof | |
| CA2345521A1 (en) | Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration | |
| HU227813B1 (en) | Pharmaceutical composition for the treatment of psychosis |